Medicare Enrolled
Dr. Thomas Pearson, M.D.
Neurology · Palm Harbor, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pearson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pearson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pearson
Dr. Thomas Pearson is a neurology specialist in Palm Harbor, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pearson performed 2,386 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Pearson received a total of $155,528 from 49 pharmaceutical and/or device companies across 648 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pearson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 18% volume in FL
$155,528 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 111267 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗2,386
Medicare services
Top 18% in FL for neurology
Not available
Unique patients (not deduplicated)
$126
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
836 | $92 | $179 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
357 | $329 | $2,784 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
304 | $80 | $125 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
263 | $73 | $624 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
184 | $121 | $237 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
119 | $134 | $1,152 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
104 | $125 | $248 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
88 | $39 | $65 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
78 | $32 | $55 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $56 | $134 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
17 | $163 | $1,380 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $84 | $154 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$155,528
Total received (2018-2024)
Avg $22,218/year across 7 years
Top 4% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
648
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,762
2023
$31,762
2022
$28,996
2021
$49,302
2020
$17,085
2019
$1,249
2018
$19,373
Payments by company (2024)
ABBVIE INC.
$7,086
CATALYST PHARMACEUTICALS, INC.
$119
PFIZER INC.
$97
Lundbeck LLC
$92
UCB, Inc.
$72
Novartis Pharmaceuticals Corporation
$58
Neurocrine Biosciences, Inc.
$51
Otsuka America Pharmaceutical, Inc.
$46
ACADIA Pharmaceuticals Inc
$38
JAZZ PHARMACEUTICALS INC.
$38
Lilly USA, LLC
$24
ARGENX US, INC.
$24
Teva Pharmaceuticals USA, Inc.
$17
Top 3 companies account for 94.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$64,629
AbbVie Inc.
$44,522
Allergan, Inc.
$19,932
Merck Sharp & Dohme Corporation
$17,846
IDORSIA PHARMACEUTICALS US INC
$1,497
Sunovion Pharmaceuticals Inc.
$754
Amgen Inc.
$509
Neurocrine Biosciences, Inc.
$480
Lilly USA, LLC
$469
Eisai Inc.
$417
Supernus Pharmaceuticals, Inc.
$358
Teva Pharmaceuticals USA, Inc.
$356
PFIZER INC.
$295
Neuronetics, Inc.
$285
Novartis Pharmaceuticals Corporation
$284
Biohaven Pharmaceuticals, Inc.
$260
JAZZ PHARMACEUTICALS INC.
$229
GE HEALTHCARE
$222
Lundbeck LLC
$218
Abbott Laboratories
$191
Biohaven Pharmaceutical Holding Company Ltd.
$141
Allergan Inc.
$137
ACADIA Pharmaceuticals Inc
$133
UCB, Inc.
$121
CATALYST PHARMACEUTICALS, INC.
$119
Harmony Biosciences LLC
$116
Kyowa Kirin, Inc.
$100
Amneal Pharmaceuticals LLC
$93
Otsuka America Pharmaceutical, Inc.
$88
Jazz Pharmaceuticals Inc.
$87
Avanir Pharmaceuticals, Inc.
$82
Axsome Therapeutics, Inc.
$73
Adamas Pharmaceuticals, Inc.
$56
Catalyst Pharmaceuticals, Inc.
$47
Merck Sharp & Dohme LLC
$45
Acorda Therapeutics, Inc
$42
EISAI INC.
$39
Avion Pharmaceuticals
$33
Alexion Pharmaceuticals, Inc.
$32
EMD Serono, Inc.
$29
HARMONY BIOSCIENCES LLC
$27
ARGENX US, INC.
$24
Bayer HealthCare Pharmaceuticals Inc.
$19
Sumitomo Pharma America, Inc.
$17
MDD US Operations, LLC
$17
Genentech USA, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$16
Azurity Pharmaceuticals, Inc.
$15
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 83.0% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUSTEDO · Aimovig · Austedo XR · BELSOMRA · Betaseron · Briviact · COMIRNATY · COPAXONE · DUOPA · Dayvigo · Dhivy · EMGALITY · FYCOMPA · Fycompa · GILENYA · GOCOVRI · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KYNMOBI · LYRICA · Mavenclad · NAMZARIC · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · ONGENTYS · OXTELLAR XR · Ongentys · PAXLOVID · Pacemakers · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SUNOSI · Sunosi · TROKENDI XR · UBRELVY · VRAYLAR · VYEPTI · VYVGART HYTRULO · WAKIX · Wakix · XYREM · XYWAV · Xyrem
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
175
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
MEASE DUNEDIN HOSPITAL
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pearson is a clinical cardiology specialist, with above-average Medicare volume (top 18% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pearson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pearson performed 836 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pearson receive payments from pharmaceutical companies?
Yes. Dr. Pearson received a total of $155,528 from 49 companies across 648 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pearson's costs compare to other neurologists in Palm Harbor?
Dr. Pearson's average Medicare payment per service is $126. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pearson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Palm Harbor
Browse neurologists in Palm Harbor ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology